Uday R Popat

59PUBLICATIONS
189CO-AUTHORS
HaematologyCancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursPredictive and prognostic markersReproduction
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (59)

|Jun 17, 2026
Donor-specific HLA mismatch: haploidentical versus 7/8 mismatched unrelated donor hematopoietic cell transplantation with PTCy.

|May 27, 2026
Long-Term Outcomes of Azacitidine, Venetoclax and Gilteritinib in Newly Diagnosed FLT3-Mutated AML.

|May 13, 2026
Late Cytomegalovirus Infections After Allogeneic Hematopoietic Cell Transplant.

|May 06, 2026
Prognostic impact of ASXL1 mutations in acute myeloid leukemia treated with lower intensity therapy.

|Apr 26, 2026
Cladribine With Low-Dose Cytarabine and Venetoclax Alternating With Azacitidine and Venetoclax for Newly Diagnosed Acute Myeloid Leukemia.

|Mar 04, 2026
Evaluating the Impact of Fewer Frontline Intensive Chemotherapy Plus Venetoclax Consolidation Cycles on Outcomes in AML.

Jennifer Marvin-Peek, Hagop Kantarjian, Wei-Ying Jen

Pageof 10

Frequent Collaborators

24 joint publications

Richard E Champlin

15 joint publications

Naval G Daver

15 joint publications

Nicholas Short

14 joint publications

Tapan M Kadia